These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 11934590)

  • 1. Chemical logic of MraY inhibition by antibacterial nucleoside natural products.
    Mashalidis EH; Kaeser B; Terasawa Y; Katsuyama A; Kwon DY; Lee K; Hong J; Ichikawa S; Lee SY
    Nat Commun; 2019 Jul; 10(1):2917. PubMed ID: 31266949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a natural product optimization strategy for inhibitors against MraY, a promising antibacterial target.
    Yamamoto K; Sato T; Hao A; Asao K; Kaguchi R; Kusaka S; Ruddarraju RR; Kazamori D; Seo K; Takahashi S; Horiuchi M; Yokota SI; Lee SY; Ichikawa S
    Nat Commun; 2024 Jun; 15(1):5085. PubMed ID: 38877016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold.
    Okamoto K; Ishikawa A; Okawa R; Yamamoto K; Sato T; Yokota SI; Chiba K; Ichikawa S
    Bioorg Med Chem; 2022 Feb; 55():116556. PubMed ID: 35016115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand Shaping in Induced Fit Docking of MraY Inhibitors. Polynomial Discriminant and Laplacian Operator as Biological Activity Descriptors.
    Lungu CN; Diudea MV; Putz MV
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28653980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold" Bioorganic & Medicinal Chemistry 55 (2021) 116556.
    Okamoto K; Ishikawa A; Okawa R; Yamamoto K; Sato T; Yokota SI; Chiba K; Ichikawa S
    Bioorg Med Chem; 2022 May; 61():116689. PubMed ID: 35272912
    [No Abstract]   [Full Text] [Related]  

  • 6. The challenges and opportunities of developing small molecule inhibitors of MraY.
    Manning D; Huang TY; Berida T; Roy S
    Annu Rep Med Chem; 2023; 60():1-27. PubMed ID: 39015353
    [No Abstract]   [Full Text] [Related]  

  • 7. New MraY
    Wan H; Ben Othman R; Le Corre L; Poinsot M; Oliver M; Amoroso A; Joris B; Touzé T; Auger R; Calvet-Vitale S; Bosco M; Gravier-Pelletier C
    Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36139968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential non-nucleoside MraY inhibitors for tuberculosis chemotherapy using structure-based virtual screening.
    Pandey P; Chatterjee S; Berida T; Doerksen RJ; Roy S
    J Biomol Struct Dyn; 2022 Jul; 40(11):4832-4849. PubMed ID: 33353500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of nucleoside antibacterial natural product antibiotics.
    Bugg TDH; Kerr RV
    J Antibiot (Tokyo); 2019 Dec; 72(12):865-876. PubMed ID: 31471595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Membrane Steps of Bacterial Cell Wall Synthesis as Antibiotic Targets.
    Liu Y; Breukink E
    Antibiotics (Basel); 2016 Aug; 5(3):. PubMed ID: 27571111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
    Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
    Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic origin and mechanism of formation of the aminoribosyl moiety of peptidyl nucleoside antibiotics.
    Chi X; Pahari P; Nonaka K; Van Lanen SG
    J Am Chem Soc; 2011 Sep; 133(36):14452-9. PubMed ID: 21819104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise synthesis of capuramycin.
    Kurosu M; Li K; Crick DC
    Org Lett; 2009 Jun; 11(11):2393-6. PubMed ID: 19405507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence detection-based functional assay for high-throughput screening for MraY.
    Stachyra T; Dini C; Ferrari P; Bouhss A; van Heijenoort J; Mengin-Lecreulx D; Blanot D; Biton J; Le Beller D
    Antimicrob Agents Chemother; 2004 Mar; 48(3):897-902. PubMed ID: 14982781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of sub-micromolar inhibitors of MraY by exploring the region originally occupied by the diazepanone ring in the liposidomycin structure.
    Dini C; Didier-Laurent S; Drochon N; Feteanu S; Guillot JC; Monti F; Uridat E; Zhang J; Aszodi J
    Bioorg Med Chem Lett; 2002 Apr; 12(8):1209-13. PubMed ID: 11934590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of a diazepanone-based library of liposidomycins analogs as MraY inhibitors.
    Mravljak J; Monasson O; Al-Dabbagh B; Crouvoisier M; Bouhss A; Gravier-Pelletier C; Le Merrer Y
    Eur J Med Chem; 2011 May; 46(5):1582-92. PubMed ID: 21377772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors.
    Dini C; Collette P; Drochon N; Guillot JC; Lemoine G; Mauvais P; Aszodi J
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1839-43. PubMed ID: 10969981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of analogues of the O-beta-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 2: role of the hydroxyl groups upon the inhibition of MraY.
    Dini C; Drochon N; Guillot JC; Mauvais P; Walter P; Aszodi J
    Bioorg Med Chem Lett; 2001 Feb; 11(4):533-6. PubMed ID: 11229764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caprazamycins: Biosynthesis and structure activity relationship studies.
    Wiker F; Hauck N; Grond S; Gust B
    Int J Med Microbiol; 2019 Jul; 309(5):319-324. PubMed ID: 31138496
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.